Important note

This AI stock analysis for Neogen is not up to date. Creating and accessing our AI stock Analysis (powered by our data and Chat GPT) is only available for our premium users. Sign up to get access today!

Neogen - AI Stock Analysis

Analysis generated February 29, 2024

Neogen Corporation is a high-growth company that provides a diverse range of solutions for food and animal safety. It designs, manufactures, and markets a suite of products dedicated to ensuring the safety and quality of food and pharmaceuticals, along with maintaining health and nutritional standards in animals. The demand for such safety measures is continuously on the rise in response to increasing global health awareness and stringent regulatory environments. Neogen serves a growing market bookended by consumers increasingly interested in transparency regarding food sources and production practices.

Fundamental Analysis

Neogen's revenue for the last quarter was $449M, denoting a slight decrease of 0.30% when compared to the preceding quarter. While this sequential dip might be cause for some concern, the 5.37% year-over-year increase in revenue suggests that the company is still on a growth trajectory and is able to increase its overall sales volume over time.

The net income figure for Neogen was $3.5M, a significant decrease of 332.00% from the quarter before. This steep decline raises flags about profitability and operational efficiency over the recent term. Still, the 91.67% increase when matched against the same quarter from last year puts a positive spin on long-term growth.

Earnings before interest, taxes, depreciation, and amortization (EBITDA) came in at $30M. This posting, a 16.00% quarter-over-quarter decrease, may require thoughtful analysis to understand if it correlates to cyclical trends or highlights underlying issues. Despite this, the figure marks a 1,144.35% increase on a year-over-year basis, underscoring robust fundamentals.

The current price-to-earnings (P/E) ratio stands at 168.6, suggesting a rather high valuation that may signal overvaluation and pessimistic future stock performance projections by the market participants.

Technical Analysis

As of today, Neogen's stock price is $17.46. This price represents an increase of 8.31% over the past month and a bullish signal in short-term price momentum. Yet, the decline of 6.98% from the same time last year raises concerns over the long-term trend and overall market confidence in the stock.

The simple moving average for the last 10 days (SMA10) is $17.25, which is slightly higher than the preceding SMA10 of $17.19. This incremental increase leans towards a continuing upward trend in price movement. However, the Relative Strength Index (RSI) is at 46.1, landing the stock in a neutral condition and potentially indicating that it is neither overbought nor oversold at the moment.

Alternative Data Analysis

Neogen's job postings have decreased by 8% in the past few months, indicating possible cost-cutting measures or an efficiency drive. For an expanding company, this trend might display a pivot in strategy or a red flag towards future growth.

Web page visits are rising for Neogen, with a 6% increase indicating potentially higher customer acquisition rates. This metric can often correlate with sales and market interest momentum, suggesting a bullish trend for the company.

Neogen's social media presence, as shown by their Instagram and Twitter followers, has remained stagnant without significant increases or decreases. Engagement on these platforms can reflect brand strength and customer interest levels, so a lack of movement could imply the need for more vigorous marketing efforts.

Conclusion and Recommendation

Neogen presents a mixed picture based on available data. Solid year-over-year revenue and EBITDA growth suggest healthy market demand and potentially effective management execution. However, sequential declines in net income and EBITDA paired with a high P/E ratio may wave caution flags. A neutral RSI and a moderate increase in short-term stock price with a decrease relative to last year indicate uncertainty in immediate price direction.

Given the mixed technical and fundamental indicators coupled with tepid alternative data signals, potential investors should approach Neogen with a cautious outlook. Investors currently holding Neogen may benefit from closely monitoring upcoming quarterly results and management commentary to adjust their investment thesis if necessary. New investors might consider waiting for more definitive signals of growth or price stabilization before taking positions.